SCHEMBL168302

SCHEMBL168302

CCOc1cn(-c2ccc(F)cc2)nc1C(N)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.56
RAB9A P51151 5/20 0.56
LMNA P02545 2/20 0.56
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 4/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
RXFP1 Q9HBX9 2/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
GABRA2 P47869 1/20 0.41
GABRB2 P47870 1/20 0.41
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL176297 0.88 NPC1 (0.57) NPC1RAB9ALMNAKDM4EALDH1A1
SCHEMBL176089 0.87 NPC1 (0.56) NPC1RAB9ALMNAKDM4EALDH1A1
SCHEMBL164282 0.86 NPC1 (0.47) NPC1RAB9ALMNAKDM4EKMT2A
SCHEMBL168121 0.86 NPC1 (0.73) NPC1RAB9ALMNAKDM4EALDH1A1
SCHEMBL168201 0.85 KMT2A (0.50) NPC1RAB9ALMNAKDM4EALDH1A1
SCHEMBL164749 0.82 AURKA (0.51) NPC1RAB9ALMNAKDM4EALDH1A1
SCHEMBL167753 0.82 NPC1 (0.47) NPC1RAB9ALMNAKDM4EALDH1A1
Hydrochloric Acid SCHEMBL30297750 0.81 AURKA (0.51) NPC1RAB9ALMNAKDM4EALDH1A1
SCHEMBL168443 0.77 AURKA (0.41) NPC1RAB9ALMNAKDM4EALDH1A1
SCHEMBL30367344 0.76 NPC1 (0.65) NPC1RAB9ALMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609091-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS Lead Discovery Center GmbH (DE) 2013-07-03 EP disclosed
WO-2012028332-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2012-03-08 WO disclosed